Evidence map›Paper›PMID 39518949›Full record

Observational studyInternational journal of molecular sciences2024

Exploring the Chemopreventive Effect of Medication on Gene Expression Linked to Colorectal Cancer: An Observational and Mendelian Randomization Analysis in Healthy Colon Mucosa.

Ferran Moratalla-Navarro, Robert Carreras-Torres, Virginia Díez-Obrero, Matthew Devall, Mireia Obón-Santacana, Anna Díez-Villanueva, Elisabet Guinó, Graham Casey, Li Li, Victor Moreno

Abstract readObservational Study
In one paragraph

Observational study in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ferran Moratalla-NavarroOncology Data Analytics Program, Catalan Institute of Oncology, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0001-7858-5713
Robert Carreras-TorresColorectal Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology (ONCOBELL) Program, Bellvitge Biomedical Research Institute, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-2925-734X
Virginia Díez-ObreroOncology Data Analytics Program, Catalan Institute of Oncology, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Matthew DevallDepartment of Family Medicine, University of Virginia, Charlottesville, VA 22903, USA.ORCID 0000-0001-5943-4397
Mireia Obón-SantacanaOncology Data Analytics Program, Catalan Institute of Oncology, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0003-4646-3513
Anna Díez-VillanuevaOncology Data Analytics Program, Catalan Institute of Oncology, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Elisabet GuinóOncology Data Analytics Program, Catalan Institute of Oncology, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
Graham CaseyDepartment of Genome Sciences, University of Virginia, Charlottesville, VA 22903, USA.
Li LiDepartment of Family Medicine, University of Virginia, Charlottesville, VA 22903, USA.ORCID 0000-0003-1802-9517
Victor MorenoOncology Data Analytics Program, Catalan Institute of Oncology, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-2818-5487

Funding

Using Functional Genomics to Inform Gene Environment Interactions for Colorectal CancerR01CA201407 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GAUDERMAN, WILLIAM JAMES, LE MARCHAND, LOIC · 2016 to 2020
$9.6M
Inherited colorectal cancer risk variants: from association to biologyR01CA143237 · NCI · UNIVERSITY OF VIRGINIA · PI CASEY, GRAHAM · 2010 to 2020
$8.4M
An integrative omics approach to investigate gene-environment interaction in colorectal cancer riskR01CA273198 · NCI · FRED HUTCHINSON CANCER CENTER · PI William JAMES GAUDERMAN, ULRIKE PETERS · 2023 to 2026
$3.5M
Biology of Colorectal Cancer Risk EnhancersR01CA204279 · NCI · UNIVERSITY OF VIRGINIA · PI CASEY, GRAHAM, SCACHERI, PETER CHRISTOPHER · 2016 to 2020
$3.0M
DISCERN HORIZON-MISS-2021-CANCER-02-03: 101096888Instituto de Salud Carlos III FORT23/00032; PI17-00092 and PI20-01439NCI NIH HHS R01 CA143237NCI NIH HHS R01 CA201407NCI NIH HHS R01 CA204279NCI NIH HHS R01 CA273198NIH HHS R01CA273198; R01 CA204279; R01 CA143237 and R01 CA201407
6 · The paper itself

Abstract

Gene expression appears altered in apparently normal tissue surrounding tumor tissue. The observed biological alterations in the tumor microenvironment play a crucial role in cancer development and are named the cancer field effect (FE). A robust set of overexpressed FE genes in tissue surrounding colorectal cancer (CRC) tumor were identified in previous studies. Our study aimed to investigate the influence of common medication intake and modifiable risk factors on FE gene expression using a colonic mucosa sample dataset of healthy individuals (BarcUVa-Seq). We applied expression enrichment analysis of the FE genes for each studied medication and factor. Both observational and instrumental (Mendelian randomization) analysis were conducted, and the results were validated using independent datasets. The findings from the observational and instrumental analyses consistently showed that medication intake, especially metformin, considerably downregulated the FE genes. Chemopreventive effects were also noted for antihypertensive drugs targeting the renin-angiotensin system. Conversely, benzodiazepines usage might upregulate FE genes, thus fostering a tumor-promoting microenvironment. In contrast, the findings from the observational and instrumental analyses on modifiable risk factors showed some discrepancies. The instrumental results indicated that obesity and smoking might promote a tumor-favorable microenvironment. These findings offer insights into the biological mechanisms through which risk factors might influence CRC development and highlight the potential chemopreventive roles of metformin and antihypertensive drugs in CRC risk.

Indexed as

Colorectal NeoplasmsMetforminChemopreventionColonGene Expression Regulation, NeoplasticHumansIntestinal MucosaMaleMendelian Randomization AnalysisRisk FactorsTumor MicroenvironmentMetforminchemopreventioncolorectal cancergene expressionMendelian randomizationtumor microenvironment

Identifiers

PMID39518949
PMCPMC11547083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.